Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
Acta Neuropathologica · 2023
DOI: 10.1007/s00401-023-02544-6 ↗Kurz gefasst
Leserbrief in der Zeitschrift Acta Neuropathologica, 2023. Verfasst von Vivian Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco, 513 Parnassus Ave, Health Sciences West 451, San Francisco, CA, 94143, USA. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, ODCDC CDC HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of California San Francisco, 513 Parnassus Ave, Health Sciences West 451, San Francisco, CA, 94143, USA.
- Clinical Cancer Genomics Laboratory, University of California San Francisco, San Francisco, CA, USA.
- Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
- Department of Pathology, University of California San Francisco, 513 Parnassus Ave, Health Sciences West 451, San Francisco, CA, 94143, USA. clucas7@jhmi.edu.
- Department of Pathology, Johns Hopkins University School of Medicine, 1800 Orleans St, Sheikh Zayed Tower Room 2101, Baltimore, MD, 21287, USA. clucas7@jhmi.edu.
ORCID-Profile: David A Solomon
Förderung
- NIH HHS
- NCI NIH HHS
- ODCDC CDC HHS
- NIH Office of the Director
- National Cancer Institute, NIH
Zitieren
APA
Tang, V., Lu, R., Mirchia, K., Van Ziffle, J., Devine, P., Lee, J., Phillips, J. J., Perry, A., Raleigh, D. R., Lucas, C. G., & Solomon, D. A. (2023). Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02544-6
Vancouver
Tang V, Lu R, Mirchia K, Van Ziffle J, Devine P, Lee J, et al. Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. Acta Neuropathologica. 2023. doi:10.1007/s00401-023-02544-6
BibTeX
@article{Tang2023,
author = {Tang, Vivian and Lu, Rufei and Mirchia, Kanish and Van Ziffle, Jessica and Devine, Patrick and Lee, Julieann and Phillips, Joanna J and Perry, Arie and Raleigh, David R and Lucas, Calixto-Hope G and Solomon, David A},
title = {Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas},
journal = {Acta Neuropathologica},
year = {2023},
doi = {10.1007/s00401-023-02544-6}
}
EUVIMED